-
平臺編號：bio-68298
-
國際編號：CRL-3000?
-
細(xì)胞信息： Mino
-
規(guī)格：frozen
-
用途：ATCC原裝細(xì)胞
-
服務(wù)費(fèi)用：
加載中…… - 訂購
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
Mino
年限：64
組織來源：Mantle cell lymphoma (B cell non-Hodgkin's lymphoma)
器官來源：外周血
生長狀態(tài)：懸浮生長
ATCC Number：CRL-3000?
相關(guān)疾病：其他疾病
細(xì)胞形態(tài)：淋巴樣
運(yùn)輸方式：凍存運(yùn)輸
數(shù)量：大量
細(xì)胞類型：其他細(xì)胞類型
是否是腫瘤細(xì)胞：0
物種來源：人
規(guī)格：0.2ml Designations: Mino
Depositors: ?R.J.Ford
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Homo sapiens
Morphology:lymphoblast
Characterization Data
Source: Organ: peripheral blood
Tissue: Mantle cell lymphoma (B cell non-Hodgkin's lymphoma)
Cell type: lymphoblast; cytogenetic abnormality
Disease: Mantle Cell Lymphoma
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Applications:The immunophenotype by flow cytometry is compatible with MCL [PubMed: 12127561].
Antigen Expression:CD3-, CD5+, CD10-, CD19+, CD20+, CD23- (verified at ATCC )
DNA Profile (STR):Amelogenin: X,Y
CSF1PO: 9,11
D13S317: 12
D16S539: 11,12
D5S818: 11,12
D7S820: 10,11
THO1: 9.3
TPOX: 8,11
vWA: 14,17
Cytogenetic Analysis:Modal chromosome number: 74. This is a hypertriploid male cell line, del(6)(q16), t(8;11)(q22;q23), add(11)(q25), add(13)(q34), add(14)(q32). Most cells contain the t(11;14) derivative chromosome, detected by FISH with whole chromosome paint probes.
Age: 64
Gender: male
Ethnicity: Caucasian
Comments:The cells are large, growing singly and in small clumps in vitro. The immunophenotype by flow cytometry is compatible with MCL [PubMed: 12127561].Western blots show expression of cyclin D1 but no detectable cyclin D2 and cyclin D3; the retinoblastoma protein is predominantly phosphorylated. There is expression of tumor suppressor gene products including p53, p16 (INK4a), and p21(WAF1) [PubMed: 12127561].
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 15%.
Temperature: 37.0°C
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Subculturing: Cultures can be maintained by the addition of fresh medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 6 X 10(4) viable cells/ml. Do not allow the cell concentration to reach 1.5 X 10(6) cells/ml. Subcultivation Ratio: 1:5 to 1:10.
Preservation: 90% FBS; 10% (v/v) DMSO
Doubling Time: about 72 hours
References: 92889: Lai R, et al. Establishment and characterization of a new mantle cell lymphoma cell line, Mino. Leuk. Res. 26: 849-855, 2002. PubMed: 12127561
92890: Marzec M, et al. Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. Blood 108: 1744-1750, 2006. PubMed: 16690963
92895: Salaverria I, et al. Mantle cell lymphoma: from pathology and molecular pathogenesis to new therapeutic perspectives. Haematologica 91: 11-16, 2006. PubMed: 16434365
組織來源：Mantle cell lymphoma (B cell non-Hodgkin's lymphoma)
器官來源：外周血
生長狀態(tài)：懸浮生長
ATCC Number：CRL-3000?
相關(guān)疾病：其他疾病
細(xì)胞形態(tài)：淋巴樣
運(yùn)輸方式：凍存運(yùn)輸
數(shù)量：大量
細(xì)胞類型：其他細(xì)胞類型
是否是腫瘤細(xì)胞：0
物種來源：人
規(guī)格：0.2ml Designations: Mino
Depositors: ?R.J.Ford
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Homo sapiens
Morphology:lymphoblast
Characterization Data
Source: Organ: peripheral blood
Tissue: Mantle cell lymphoma (B cell non-Hodgkin's lymphoma)
Cell type: lymphoblast; cytogenetic abnormality
Disease: Mantle Cell Lymphoma
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Applications:The immunophenotype by flow cytometry is compatible with MCL [PubMed: 12127561].
Antigen Expression:CD3-, CD5+, CD10-, CD19+, CD20+, CD23- (verified at ATCC )
DNA Profile (STR):Amelogenin: X,Y
CSF1PO: 9,11
D13S317: 12
D16S539: 11,12
D5S818: 11,12
D7S820: 10,11
THO1: 9.3
TPOX: 8,11
vWA: 14,17
Cytogenetic Analysis:Modal chromosome number: 74. This is a hypertriploid male cell line, del(6)(q16), t(8;11)(q22;q23), add(11)(q25), add(13)(q34), add(14)(q32). Most cells contain the t(11;14) derivative chromosome, detected by FISH with whole chromosome paint probes.
Age: 64
Gender: male
Ethnicity: Caucasian
Comments:The cells are large, growing singly and in small clumps in vitro. The immunophenotype by flow cytometry is compatible with MCL [PubMed: 12127561].Western blots show expression of cyclin D1 but no detectable cyclin D2 and cyclin D3; the retinoblastoma protein is predominantly phosphorylated. There is expression of tumor suppressor gene products including p53, p16 (INK4a), and p21(WAF1) [PubMed: 12127561].
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 15%.
Temperature: 37.0°C
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Subculturing: Cultures can be maintained by the addition of fresh medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 6 X 10(4) viable cells/ml. Do not allow the cell concentration to reach 1.5 X 10(6) cells/ml. Subcultivation Ratio: 1:5 to 1:10.
Preservation: 90% FBS; 10% (v/v) DMSO
Doubling Time: about 72 hours
References: 92889: Lai R, et al. Establishment and characterization of a new mantle cell lymphoma cell line, Mino. Leuk. Res. 26: 849-855, 2002. PubMed: 12127561
92890: Marzec M, et al. Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. Blood 108: 1744-1750, 2006. PubMed: 16690963
92895: Salaverria I, et al. Mantle cell lymphoma: from pathology and molecular pathogenesis to new therapeutic perspectives. Haematologica 91: 11-16, 2006. PubMed: 16434365
